News & Updates
Showing Multidisciplinary articles
Showing
Show Multimedia Only

Haemorrhagic complications in COVID-19 patients linked to in-ICU mortality risk
16 Aug 2022
byRoshini Claire Anthony
A large global study of patients with severe COVID-19 admitted to the intensive care unit (ICU) has shown a 14 percent prevalence of haemorrhagic, coagulopathic, and thrombotic (HECTOR) complications in these patients, with mortality risk increased in those with haemorrhagic complications.
16 Aug 2022

Investigational nasal spray for dry eye disease scores high in phase II trial
16 Aug 2022
The single-dose nicotinic acetylcholine receptor agonist OC-02, administered as an aqueous nasal spray, helps increase tear production and improve eye dryness in patients with dry eye disease (DED), according to data from the phase II PEARL trial.
16 Aug 2022

How effective is ensovibep in hospitalized adults with COVID-19?
16 Aug 2022
byStephen Padilla
Hospitalized patients with COVID-19 who are receiving remdesivir and other standard care show no improvements in clinical outcomes with the addition of ensovibep, according to the results of a study.
16 Aug 2022





